ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
ClearPoint Neuro, Inc. (CLPT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $5.78 per share as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-03-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.78.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.78.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $6.10.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $6.16.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $5.78 10-K · filed 2026-03-17 |
| 2025-09-30 | $5.78 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.10 10-Q · filed 2025-08-12 |
| 2025-03-31 | $6.16 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.48 10-K · filed 2025-02-26 |
| 2024-09-30 | $8.28 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.30 10-Q · filed 2024-08-07 |
| 2024-03-31 | $8.33 10-Q · filed 2024-05-07 |
| 2023-12-31 | $8.40 10-K · filed 2024-03-12 |
| 2023-09-30 | $8.64 10-Q · filed 2023-11-09 |
| 2023-06-30 | $8.58 10-Q · filed 2023-08-08 |
| 2023-03-31 | $8.65 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.69 10-K · filed 2023-03-01 |
| 2021-12-31 | $10.10 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |